Edwards Lifesciences Europe — Cost of Sales increased by 3.2% to $93.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.9%, from $82.20M to $93.60M. Over 3 years (FY 2022 to FY 2025), Europe — Cost of Sales shows an upward trend with a 12.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to sales may indicate rising manufacturing costs or supply chain inefficiencies, while a decrease suggests improved production margins.
This metric captures the direct costs associated with manufacturing and delivering medical devices sold within the Europ...
Comparable to regional cost of goods sold (COGS) reported by peers in the medical technology sector.
ew_segment_europe_cost_of_sales| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $59.48M | $59.48M | $59.48M | $59.48M | $67.13M | $67.13M | $67.13M | $67.13M | $73.60M | $74.40M | $72.70M | $78.40M | $82.20M | $84.80M | $82.40M | $90.70M | $93.60M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +12.9% | +0.0% | +0.0% | +0.0% | +9.6% | +1.1% | -2.3% | +7.8% | +4.8% | +3.2% | -2.8% | +10.1% | +3.2% |
| YoY Change | — | — | — | — | +12.9% | +12.9% | +12.9% | +12.9% | +9.6% | +10.8% | +8.3% | +16.8% | +11.7% | +14.0% | +13.3% | +15.7% | +13.9% |